Cargando…
Severe panuveitis with iridis rubeosis activation and cystoid macular edema after BioNTech-Pfizer COVID-19 vaccination in a 17-year-old
We report a case of severe uveitis flare-up with iridis rubeosis recurrence and cystoid macular edema early after the first BioNTech-Pfizer COVID-19 vaccination in a 17-year-old boy. We also performed a systematic literature review on ocular inflammation after COVID-19 vaccinations.
Autores principales: | Achiron, Asaf, Tuuminen, Raimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844771/ https://www.ncbi.nlm.nih.gov/pubmed/35198809 http://dx.doi.org/10.1016/j.ajoc.2022.101380 |
Ejemplares similares
-
Tozinameran: Panuveitis, iridis rubeosis re-activation and cystoid macular oedema: case report
Publicado: (2022) -
Rubeosis iridis
por: Pagoulatos, Dionysios, et al.
Publicado: (2017) -
Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
por: Aaronson, Alexander, et al.
Publicado: (2020) -
Visible Blood Flow in a Case of Rubeosis Iridis
por: Tanito, Masaki, et al.
Publicado: (2021) -
Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination
por: Valenzuela, Daniel A., et al.
Publicado: (2021)